Filing Flows › Emmaus Life Sciences (EMMA) › Q2 2026 › vs Q1 2026
Emmaus Life Sciences (EMMA) Q2 2026 vs Q1 2026 (quarter over quarter)
Emmaus Life Sciences's revenue rose $4.3M (+219%) from $2.0M in Q1 2026 to $6.3M in Q2 2026. The biggest changes: Endari US +$4.6M (+336%); Endari International −$288K (-49%); Product and Service Other −$1K (-4%). Gross margin 94.6% against 91.5% (+3.0 pts).
Emmaus Life Sciences, Q2 2026: revenue $6.3M (+124% year over year), operating margin 60.0%, net earnings $1.3M, operating cash flow $1.7M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 94.6% | 91.5% | +3.0 pts |
| Operating margin | 60.0% | -41.5% | +101.5 pts |
| Net margin | 21.2% | -168.3% | +189.5 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Endari US | $6.0M | $1.4M | $4.6M | +336% |
| Endari International | $295K | $583K | −$288K | -49% |
| Product and Service Other | $22K | $23K | −$1K | -4% |
| Revenue | $6.3M | $2.0M | $4.3M | +219% |
| Gross profit | $6.0M | $1.8M | $4.2M | +229% |
| Cost of revenue | $344K | $168K | $176K | +105% |
| Operating profit | $3.8M | −$823K | $4.6M | — |
| Operating expenses | $2.2M | $2.6M | −$454K | -17% |
| Pre-tax earnings | $1.3M | −$3.3M | $4.7M | — |
| Other expense, net | $2.5M | $2.5M | −$55K | -2% |
| Research & development | $116K | $40K | $76K | +190% |
| Sales & marketing | $493K | $747K | −$254K | -34% |
| General & admin | $1.6M | $1.9M | −$276K | -15% |
| Income tax benefit | $1K | −$4K | $5K | — |
| Net earnings | $1.3M | −$3.3M | $4.7M | — |
| Depreciation | $14K | $15K | −$1K | -7% |
| Working capital & other | $340K | $3.0M | −$2.6M | -89% |
| Operating cash flow | $1.7M | −$344K | $2.0M | — |
Questions
How much did Emmaus Life Sciences's revenue grow quarter over quarter in Q2 2026?
Emmaus Life Sciences's revenue rose $4.3M (+219%) from $2.0M in Q1 2026 to $6.3M in Q2 2026.
What drove Emmaus Life Sciences's revenue change in Q2 2026?
Endari US +$4.6M (+336%); Endari International −$288K (-49%); Product and Service Other −$1K (-4%).